Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × Breast Neoplasms × Alpelisib × Clear all

Status

Completed 18 Active not recruiting 14 Terminated 7 Recruiting 4 Unknown 2 Withdrawn 1 No longer available 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

ribociclib 1 Proton Pump Inhibitors 1 Hydrocortisone 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04085653 2026-04-14

Managed Access Programs for BYL719, Alpelisib

Novartis

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡